abstract |
The invention relates to cell therapy, and in particular to the use of exol gene and the EXO1 enzyme in medicine, and to the uses thereof in treatment and therapy of various diseases. In particular, the invention relates to the treatment or prevention of cancer and/or aging, and to methods of carrying out such methods, including recombinant constructs encoding EXO1. |